135 related articles for article (PubMed ID: 30066914)
1. Protective role of ABCG2 against oxidative stress in colorectal cancer and its potential underlying mechanism.
Nie S; Huang Y; Shi M; Qian X; Li H; Peng C; Kong B; Zou X; Shen S
Oncol Rep; 2018 Oct; 40(4):2137-2146. PubMed ID: 30066914
[TBL] [Abstract][Full Text] [Related]
2. ABCG2 reduces ROS-mediated toxicity and inflammation: a potential role in Alzheimer's disease.
Shen S; Callaghan D; Juzwik C; Xiong H; Huang P; Zhang W
J Neurochem; 2010 Sep; 114(6):1590-604. PubMed ID: 20626554
[TBL] [Abstract][Full Text] [Related]
3. DHX9 contributes to the malignant phenotypes of colorectal cancer via activating NF-κB signaling pathway.
Liu S; He L; Wu J; Wu X; Xie L; Dai W; Chen L; Xie F; Liu Z
Cell Mol Life Sci; 2021 Dec; 78(24):8261-8281. PubMed ID: 34773477
[TBL] [Abstract][Full Text] [Related]
4. Evodiamine Suppresses ABCG2 Mediated Drug Resistance by Inhibiting p50/p65 NF-κB Pathway in Colorectal Cancer.
Sui H; Zhou LH; Zhang YL; Huang JP; Liu X; Ji Q; Fu XL; Wen HT; Chen ZS; Deng WL; Zhu HR; Li Q
J Cell Biochem; 2016 Jun; 117(6):1471-81. PubMed ID: 26590365
[TBL] [Abstract][Full Text] [Related]
5. Gastrin regulates ABCG2 to promote the migration, invasion and side populations in pancreatic cancer cells via activation of NF-κB signaling.
Wang J; Xin B; Wang H; He X; Wei W; Zhang T; Shen X
Exp Cell Res; 2016 Aug; 346(1):74-84. PubMed ID: 27264047
[TBL] [Abstract][Full Text] [Related]
6. Conditioned medium mimicking the tumor microenvironment augments chemotherapeutic resistance via ataxia‑telangiectasia mutated and nuclear factor‑κB pathways in gastric cancer cells.
Zhuang X; Li X; Zhang J; Hu Y; Hu B; Shi Y; Sun Y; Hong G
Oncol Rep; 2018 Oct; 40(4):2334-2342. PubMed ID: 30106453
[TBL] [Abstract][Full Text] [Related]
7. A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer development.
To KK; Leung WW; Ng SS
Mol Carcinog; 2017 Feb; 56(2):464-477. PubMed ID: 27253631
[TBL] [Abstract][Full Text] [Related]
8. Membranous ABCG2 expression in colorectal cancer independently correlates with shortened patient survival.
Wang X; Xia B; Liang Y; Peng L; Wang Z; Zhuo J; Wang W; Jiang B
Cancer Biomark; 2013; 13(2):81-8. PubMed ID: 23838136
[TBL] [Abstract][Full Text] [Related]
9. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.
To KK; Leung WW; Ng SS
Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386
[TBL] [Abstract][Full Text] [Related]
10. Lupeol alters ER stress-signaling pathway by downregulating ABCG2 expression to induce Oxaliplatin-resistant LoVo colorectal cancer cell apoptosis.
Chen MC; Hsu HH; Chu YY; Cheng SF; Shen CY; Lin YJ; Chen RJ; Viswanadha VP; Lin YM; Huang CY
Environ Toxicol; 2018 May; 33(5):587-593. PubMed ID: 29436100
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis.
Hsu HH; Chen MC; Baskaran R; Lin YM; Day CH; Lin YJ; Tu CC; Vijaya Padma V; Kuo WW; Huang CY
J Cell Physiol; 2018 Jul; 233(7):5458-5467. PubMed ID: 29247488
[TBL] [Abstract][Full Text] [Related]
12. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.
Yi W; Xiao E; Ding R; Luo P; Yang Y
Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871
[TBL] [Abstract][Full Text] [Related]
13. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
15. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
[TBL] [Abstract][Full Text] [Related]
16. Expression of ABCG2 associated with tumor response in metastatic colorectal cancer patients receiving first-line FOLFOX therapy--preliminary evidence.
Lin PC; Lin HH; Lin JK; Lin CC; Yang SH; Li AF; Chen WS; Chang SC
Int J Biol Markers; 2013 Jun; 28(2):182-6. PubMed ID: 23558935
[TBL] [Abstract][Full Text] [Related]
17. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
18. Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines.
Lopez JP; Wang-Rodriguez J; Chang C; Chen JS; Pardo FS; Aguilera J; Ongkeko WM
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1022-7. PubMed ID: 17938326
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of Notch1, Jagged1, NF-κB and MMP-9 in colorectal cancer patients and the relationship to clinicopathological parameters.
Zheng CG; Chen R; Xie JB; Liu CB; Jin Z; Jin C
Cancer Biomark; 2015; 15(6):889-97. PubMed ID: 26406415
[TBL] [Abstract][Full Text] [Related]
20. Antibody validation and scoring guidelines for ABCG2 immunohistochemical staining in formalin-fixed paraffin-embedded colon cancer tissue.
Cederbye CN; Palshof JA; Hansen TP; Duun-Henriksen AK; Linnemann D; Stenvang J; Nielsen DL; Brünner N; Viuff BM
Sci Rep; 2016 Jun; 6():26997. PubMed ID: 27257141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]